Anmeldung erfolgt in Kürze...
Details werden geladen...
VERAXA Biotech AG: VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
ZURICH, SWITZERLAND - July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA"), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief
Ähnliche Seiten
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister | The Manila Times
https://www.manilatimes.net/2026/07/11/tmt-newswire/globenewswire/veraxa-biotech-ag-appoints-carl-von-halem-as-interimchief-financial-officer-and-successor-to-torsten-burgermeister/2382614
Biovica International: Biovica Appoints Maria Ekdahl as New Chief Financial Officer
https://www.finanznachrichten.de/nachrichten-2026-07/68962114-biovica-international-biovica-appoints-maria-ekdahl-as-new-chief-financial-officer-200.htmDepot Connect International (DCI) Appoints Stan Kolev as Chief Financial Officer
https://www.finanznachrichten.de/nachrichten-2026-07/68951690-depot-connect-international-dci-appoints-stan-kolev-as-chief-financial-officer-008.htmVERAXA Biotech AG: VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC-TCE Program
https://www.finanznachrichten.de/nachrichten-2026-07/68927462-veraxa-biotech-ag-veraxa-biotech-initiates-cell-line-development-with-atum-to-advance-its-lead-bitac-tce-program-399.htmIREN Appoints Chief Product Officer and Chief Development Officer | The Manila Times
https://www.manilatimes.net/2026/07/02/tmt-newswire/globenewswire/iren-appoints-chief-product-officer-and-chief-development-officer/2377422